Posted by Hello321 on August 2, 2016, at 19:34:31
In reply to Re: orthomolecular, posted by Tabitha on August 2, 2016, at 18:49:46
Doesnt matter so much ifna treatment failed in cal trial after clinical trial, if that treatment still helps you. When you dont know the cause of a condition, you wont know the fix, either. But sometimes youre lucky enough to stumble upon it. Medication wise.
The best treatment for my depression had been Periactin until it stopped working. But a mental health professional would likely never even consider prescribing periactin if i didnt specifically ask for it. Its not even a typical off label treatment for any psychiatric symptoms. But it is the best medication ive ever tried. I wouldnt doubt that if periactin were put through clinical trials for depression, that it could fail. It might help only 10 percent of those who try it. So there is a problem with saying a treatment isnt worth bringing to market for an illness even if it had only helped less than half who tried it. What really needs to be looked at is the biological effects of a med, and not what condition it is designated for. Addyi is a 5ht1a agonist that i wouldnt doubt could be very help for certain psychiatric conditions, but it only approved for Female Sexual Dysfunction. This medication probably doesnt even cross the mind of many psychiatrists.
poster:Hello321
thread:1090994
URL: http://www.dr-bob.org/babble/20160713/msgs/1091110.html